Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions

Small cell lung cancer (SCLC) is a recalcitrant malignancy with elusive mechanism of pathogenesis and dismal prognosis. Over the past decades, platinum-based chemotherapy has been the backbone treatment for SCLC. However, subsequent chemoresistance after initial effectiveness urges researchers to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chenyue, Zhang, Chenxing, Wang, Kai, Wang, Haiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349514/
https://www.ncbi.nlm.nih.gov/pubmed/37452395
http://dx.doi.org/10.1186/s12967-023-04338-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349514/
https://www.ncbi.nlm.nih.gov/pubmed/37452395
http://dx.doi.org/10.1186/s12967-023-04338-6

Ejemplares similares